Neurotron Biotechnology

About:

Neurotron Biotechnology is a China-based medical device company developing spine-related products.

Website: http://nurotronus.com/

Top Investors: Kleiner Perkins, DT Capital Partners

Description:

Nurotron Biotechnology is a medical device company that designs, develops and markets neurostimulation systems. The company’s flagship product is the Venus Cochlear Implant System. Nurotron’s patent portfolio also includes an auditory brainstem implant, artificial retina system, and systems to treat paralysis due to stroke. Founded in 2006, Nurotron maintains its research and development center in Irvine, Calif., and manufacturing facilities in Hangzhou, China.

Total Funding Amount:

$16.5M

Headquarters Location:

Hangzhou, Zhejiang, China

Founded Date:

2006-01-01

Contact Email:

info(AT)nurotron.com

Founders:

Fan-Gang Zeng, Fangping Li

Number of Employees:

1-10

Last Funding Date:

2013-12-27

IPO Status:

Private

Industries:

© 2025 bioDAO.ai